Current eye research · 2025
Exogenous All-Trans Retinoic Acid Induces Similar Longitudinal Changes in Ocular Biometry to Hyperopic Defocus in Mice.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhan Biyun, Huang Yangyi, Wang Xuejun, Ten Weijung, Wang Yuliang, Zhou Xingtao
Аннотация
PURPOSE: This study aims to investigate the longitudinal changes in ocular biometry in mice treated with exogenous all-trans retinoic acid (atRA) and make comparisons with the lens-induced myopia (LIM) model.
MATERIALS AND METHODS: Male C57BL/6J mice were administered 10 µl of atRA (1 milligram [mg]/milliliter [mL]) every other two days via peribulbar injection. The LIM group received monocular -30D lenses. Ocular biometrics were measured on Days 0, 3, 6, 10, and 15 using swept-source optical coherence tomography. Scleral thickness (ST) and retinal arc length (RAL) were measured on histological sections.
RESULTS: Both exogenous atRA and negative lenses induced longer axial length (AL) from Day 3 and thinner retinal thickness (RT) from Day 6 (all p < 0.05). An increase in vitreous chamber depth (VCD) was noted from Day 3 in atRA-Treated (p = 0.001) eyes and from Day 6 in LIM-Treated eyes (p < 0.001). The interocular difference in lens thickness (LT) varied significantly over time (p = 0.004) in the atRA group. The LT to AL ratios (LT/AL) for atRA-Treated eyes were notably higher than those for the LIM eyes on Days 10 and 15 (all p < 0.05). The VCD to AL ratios (VCD/AL) were comparable between the two groups, with notable declines observed in the late stage (all p < 0.01). Additionally, both treatment groups showed similarly reduced ST and larger RAL than untreated eyes.
CONCLUSIONS: Mice treated with exogenous atRA demonstrated comparable longitudinal ocular biometric alterations to the LIM model, except for the relatively thicker lenses.
MATERIALS AND METHODS: Male C57BL/6J mice were administered 10 µl of atRA (1 milligram [mg]/milliliter [mL]) every other two days via peribulbar injection. The LIM group received monocular -30D lenses. Ocular biometrics were measured on Days 0, 3, 6, 10, and 15 using swept-source optical coherence tomography. Scleral thickness (ST) and retinal arc length (RAL) were measured on histological sections.
RESULTS: Both exogenous atRA and negative lenses induced longer axial length (AL) from Day 3 and thinner retinal thickness (RT) from Day 6 (all p < 0.05). An increase in vitreous chamber depth (VCD) was noted from Day 3 in atRA-Treated (p = 0.001) eyes and from Day 6 in LIM-Treated eyes (p < 0.001). The interocular difference in lens thickness (LT) varied significantly over time (p = 0.004) in the atRA group. The LT to AL ratios (LT/AL) for atRA-Treated eyes were notably higher than those for the LIM eyes on Days 10 and 15 (all p < 0.05). The VCD to AL ratios (VCD/AL) were comparable between the two groups, with notable declines observed in the late stage (all p < 0.01). Additionally, both treatment groups showed similarly reduced ST and larger RAL than untreated eyes.
CONCLUSIONS: Mice treated with exogenous atRA demonstrated comparable longitudinal ocular biometric alterations to the LIM model, except for the relatively thicker lenses.